BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2015 8:33:00 AM | Browse: 453 | Download: 796
Publication Name World Journal of Experimental Medicine
Manuscript ID 17771
Country/Territory Canada
Received
2015-03-23 15:29
Peer-Review Started
2015-03-25 19:45
To Make the First Decision
2015-04-10 17:40
Return for Revision
2015-04-17 10:48
Revised
2015-04-22 03:36
Second Decision
2015-06-12 16:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-06-19 17:57
Articles in Press
2015-06-19 17:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
2015-06-25 00:51
Typeset the Manuscript
2015-08-13 20:20
Publish the Manuscript Online
2015-08-26 08:36
ISSN 2220-315x (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research and Experimental
Manuscript Type Retrospective Study
Article Title Eribulin for heavily pre-treated metastatic breast cancer patients
Manuscript Source Invited Manuscript
All Author List Antonia Digklia and Ioannis A Voutsadakis
Funding Agency and Grant Number
Corresponding author Ioannis A Voutsadakis, MD, PhD, Division of Medical Oncology, Department of Medicine, Sault Area Hospital, 750 Great Northern Road, Sault Ste Marie, Ontario ON P6B 0A8, Canada. ivoutsadakis@yahoo.com
Keywords Breast cancer; Metastatic; Eribulin; Case series; Retrospective; Treatment
Core Tip This report discusses treatment with eribulin in clinical practice outside a clinical trial setting. It confirms the activity of eribulin in a heavily pre-treated metastatic breast cancer population.
Publish Date 2015-08-26 08:36
Citation Digklia A, Voutsadakis IA. Eribulin for heavily pre-treated metastatic breast cancer patients. World J Exp Med 2015; 5(3): 194-199
Url http://www.wjgnet.com/2220-315X/full/v5/i3/194.htm
DOI http://dx.doi.org/10.5493/wjem.v5.i3.194
Full Article (PDF) WJEM-5-194.pdf
Full Article (Word) WJEM-5-194.doc
Manuscript File 17771-Review.doc
Answering Reviewers 17771-Answering reviewers.pdf
Audio Core Tip 17771-Audio core tip.wma
Biostatistics Review Certificate 17771-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 17771-Conflict-of-interest statement.pdf
Copyright License Agreement 17771-Copyright assignment.pdf
Data Sharing Statement 17771-Data sharing statement.pdf
Institutional Review Board Approval Form or Document 17771-Institutional review board statement.pdf
Peer-review Report 17771-Peer-review(s).pdf
Scientific Misconduct Check 17771-Scientific misconduct check.pdf
Scientific Editor Work List 17771-Scientific editor work list.pdf